Explainable Machine Learning and Deep Learning Models for Predicting TAS2R-Bitter Molecule Interactions
Francesco Ferri, Marco Cannariato, Lorenzo Pallante, Eric A. Zizzi,, Marco A. Deriu

TL;DR
This paper develops and combines machine learning and deep learning models to predict and explain interactions between bitter molecules and TAS2R receptors, aiding taste perception understanding and drug design.
Contribution
It introduces high-performance, explainable ML and DL models for TAS2R ligand prediction, integrating methods to improve interpretability and molecular understanding.
Findings
Models achieve high predictive accuracy.
Combined models enhance explainability.
Facilitates design of targeted bitter compounds.
Abstract
This work aims to develop explainable models to predict the interactions between bitter molecules and TAS2Rs via traditional machine-learning and deep-learning methods starting from experimentally validated data. Bitterness is one of the five basic taste modalities that can be perceived by humans and other mammals. It is mediated by a family of G protein-coupled receptors (GPCRs), namely taste receptor type 2 (TAS2R) or bitter taste receptors. Furthermore, TAS2Rs participate in numerous functions beyond the gustatory system and have implications for various diseases due to their expression in various extra-oral tissues. For this reason, predicting the specific ligand-TAS2Rs interactions can be useful not only in the field of taste perception but also in the broader context of drug design. Considering that in-vitro screening of potential TAS2R ligands is expensive and time-consuming,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMachine Learning in Materials Science · Innovative Microfluidic and Catalytic Techniques Innovation · Computational Drug Discovery Methods
